SS2. Introducing a new nutritional approach in early AD
Detailed Programme, abstracts and presentations
SS2. Introducing a new nutritional approach in early AD (Friday, 5 October, 17.30–18.30, Europa 1)
Introducing a new concept in early AD
Dr. Richard Wurtman, USA
The Souvenaid clinical trials programme
Dr. Christine von Arnim, Germany
Note: The information presented in this scientific symposium is intended for healthcare professionals. Souvenaid is a "Food for Special Medical Purposes" for the dietary management of early Alzheimer's disease and is intended for use under medical supervision.
This special symposium is sponsored by Nutricia.
Last Updated: Montag, 24. September 2012